WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Stock Ownership - Who owns Anika Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Anika Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David ColleranEVP General Counsel Corp Sec2025-03-112,250$16.79
$37.78kSell
Cheryl R. BlanchardPresident CEO Director2025-03-1112,675$16.79
$212.81kSell
Anne NunesSVP Chief Operations Officer2025-03-11752$16.79
$12.63kSell
Cheryl R. BlanchardPresident CEO Director2025-03-105,871$16.62
$97.58kSell
Anne NunesSVP Chief Operations Officer2025-03-10959$16.62
$15.94kSell
David ColleranEVP General Counsel Corp Sec2025-03-101,604$16.62
$26.66kSell
Anne NunesSVP Chief Operations Officer2024-10-01732$24.27
$17.77kSell

1 of 1

ANIK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIK insiders and whales buy or sell their stock.

ANIK Shareholders

What type of owners hold Anika Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Trigran Investments Inc13.80%2,021,778$30.75MInstitution
Blackrock Inc10.64%1,557,882$23.70MInstitution
Caligan Partners LP9.80%1,435,130$21.83MInstitution
Farmaceutici Spa Fidia9.71%1,422,384$21.63MInsider
Vanguard Group Inc5.23%765,270$11.64MInstitution
Alta Fundamental Advisers LLC4.78%700,432$10.65MInstitution
Dimensional Fund Advisors LP4.49%657,355$10.00MInstitution
Boothbay Fund Management LLC3.62%529,503$8.05MInstitution
Renaissance Technologies LLC3.61%528,517$8.04MInstitution
Acadian Asset Management LLC3.25%475,713$7.24MInstitution

1 of 3

ANIK vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIK83.34%16.66%Net SellingNet Selling
RCEL24.44%3.63%Net BuyingNet Buying
NVRO71.75%28.25%Net SellingNet Selling
ELMD26.79%73.21%Net SellingNet Selling
INGN71.10%28.90%Net SellingNet Selling
View Top Medical Device Stocks

Anika Therapeutics Stock Ownership FAQ

Who owns Anika Therapeutics?

Anika Therapeutics (NASDAQ: ANIK) is owned by 85.55% institutional shareholders, 17.11% Anika Therapeutics insiders, and 0.00% retail investors. Farmaceutici Spa Fidia is the largest individual Anika Therapeutics shareholder, owning 1.42M shares representing 9.71% of the company. Farmaceutici Spa Fidia's Anika Therapeutics shares are currently valued at $22.63M.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.